Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenance Therapy in France
Clinical trial NCT06565975 · COMPLETED
Trial details
- NCT number
- NCT06565975
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-23
- Primary completion
- 2026-01-26
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.